Approval · Notice of Compliance 36079 · 2025
MNEXSPIKE: Notice of Compliance 36079
Issued September 29, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36079
- Date
- September 29, 2025
- Company
- Moderna Biopharma Canada CorporationToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MNEXSPIKE | 02561433 | Approved |
Medicinal ingredients
- MRNA ENCODING SARS-COV-2 SPIKE PROTEIN NTD-RBD SUBDOMAINS 10 MCG per 0.2ML